| 1 | 20406806 | MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. | J Biol Chem | 2010 Jun 18 |
6 |
| 2 | 20504344 | MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. | Mol Cancer | 2010 May 26 |
1 |
| 3 | 21246413 | Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. | J Gastrointest Surg | 2011 Mar |
4 |
| 4 | 21796641 | MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. | Biopharm Drug Dispos | 2011 Sep |
2 |
| 5 | 21971665 | Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. | Oncol Rep | 2012 Feb |
1 |
| 6 | 22890324 | Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. | Oncogene | 2013 Jul 4 |
2 |
| 7 | 23376192 | Pharmaco-miR: linking microRNAs and drug effects. | Brief Bioinform | 2014 Jul |
4 |
| 8 | 23975374 | MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. | Tumour Biol | 2014 Jan |
1 |
| 9 | 24283384 | MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. | Cancer Sci | 2014 Feb |
1 |
| 10 | 24575833 | A microRNA meta-signature for pancreatic ductal adenocarcinoma. | Expert Rev Mol Diagn | 2014 Apr |
1 |
| 11 | 24662333 | A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer. | Clin Gastroenterol Hepatol | 2014 Oct |
1 |
| 12 | 24806207 | The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells. | PLoS One | 2014 |
1 |
| 13 | 24920927 | Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers. | Onco Targets Ther | 2014 |
2 |
| 14 | 25371718 | Human leukocyte antigen G and miR-148a are associated with the pathogenesis of intrahepatic cholestasis of pregnancy. | Exp Ther Med | 2014 Dec |
1 |
| 15 | 25444499 | Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues. | Eur J Med Res | 2014 Dec 2 |
2 |
| 16 | 25928008 | Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer. | J Transl Med | 2015 Apr 25 |
1 |
| 17 | 25980823 | Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling. | Mol Carcinog | 2016 May |
4 |
| 18 | 26004124 | MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3. | Mol Med Rep | 2015 Sep |
2 |
| 19 | 26097868 | MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1. | Oncoscience | 2015 |
1 |
| 20 | 26106521 | Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo. | FEBS Open Bio | 2015 |
6 |
| 21 | 26111756 | Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a. | Cell Physiol Biochem | 2015 |
1 |
| 22 | 26389729 | Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer. | Pathobiology | 2015 |
2 |
| 23 | 26429200 | MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation. | Exp Biol Med (Maywood) | 2016 Feb |
1 |
| 24 | 26638007 | Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2. | Med Sci Monit | 2015 Dec 6 |
1 |
| 25 | 26850992 | Interaction of Insulin Resistance and Related Genetic Variants With Triglyceride-Associated Genetic Variants. | Circ Cardiovasc Genet | 2016 Apr |
1 |
| 26 | 27385266 | DNA methylation based biomarkers in colorectal cancer: A systematic review. | Biochim Biophys Acta | 2016 Aug |
1 |
| 27 | 27421476 | Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis. | J Immunol | 2016 Aug 15 |
7 |
| 28 | 27591428 | miR-148a and miR-30a limit HCV-dependent suppression of the lipid droplet protein, ADRP, in HCV infected cell models. | J Med Virol | 2017 Apr |
1 |
| 29 | 27878286 | Obesity‑associated miR‑148a is regulated by cytokines and adipokines via a transcriptional mechanism. | Mol Med Rep | 2016 Dec |
1 |
| 30 | 28063929 | MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM. | Biochem Biophys Res Commun | 2017 Feb 5 |
2 |
| 31 | 28098870 | miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells. | Int J Oncol | 2017 Mar |
2 |
| 32 | 28333713 | MicroRNAs and lipid metabolism. | Curr Opin Lipidol | 2017 Jun |
1 |
| 33 | 28464803 | The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells. | BMC Cancer | 2017 May 2 |
5 |
| 34 | 28575098 | miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3. | PLoS One | 2017 |
5 |
| 35 | 28656724 | MiR-148a promotes myocardial differentiation of human bone mesenchymal stromal cells via DNA methyltransferase 1 (DNMT1). | Cell Biol Int | 2018 Aug |
1 |
| 36 | 29085372 | miR-148a-3p Mediates Notch Signaling to Promote the Differentiation and M1 Activation of Macrophages. | Front Immunol | 2017 |
3 |
| 37 | 29158814 | DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through <i>MAFG</i> Overexpression in Cancer Cells. | Theranostics | 2017 |
1 |
| 38 | 29183708 | Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins. | Semin Cell Dev Biol | 2018 Sep |
1 |
| 39 | 29475852 | Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression. | Gut | 2019 Apr |
2 |
| 40 | 29545476 | D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced <i>MIR148A</i> Promoter Methylation. | Mol Cancer Res | 2018 Jun |
2 |
| 41 | 29604247 | Involvement of microRNAs-MMPs-E-cadherin in the migration and invasion of gastric cancer cells infected with Helicobacter pylori. | Exp Cell Res | 2018 Jun 15 |
1 |
| 42 | 29749452 | MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a. | Mol Med Rep | 2018 Jul |
1 |
| 43 | 29798333 | [The expression of MiR-148a in nasopharyngeal carcinoma and its effect on tumor cell biology functions in nasopharyngeal carcinoma]. | Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2016 Aug 5 |
2 |
| 44 | 29929012 | Non-coding RNAs in lipid metabolism. | Vascul Pharmacol | 2019 Mar |
1 |
| 45 | 29931900 | [Regulation and mechanism of miR-148a on cardiomyocyte differentiation induced by 5-aza in mesenchymal stem cells]. | Zhongguo Ying Yong Sheng Li Xue Za Zhi | 2017 Jun 8 |
3 |
| 46 | 30551356 | RETRACTED: Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion. | Biomed Pharmacother | 2019 Jan |
1 |
| 47 | 30551544 | MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells. | Biomed Pharmacother | 2019 Jan |
5 |
| 48 | 30720097 | Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia. | Mol Med Rep | 2019 Apr |
2 |
| 49 | 30728365 | miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma. | Sci Rep | 2019 Feb 6 |
2 |
| 50 | 31759055 | De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties. | Exp Cell Res | 2020 Jan 15 |
2 |